On the heels of an announcement in January, Penn Medicine aka The University of Pennsylvania Health System, and Doylestown Health, formerly Doylestown Hospital, have reached an agreement on their potential merger, announced Penn Medicine last weekend.
According to Chief Healthcare Executive, state and federal regulators still need to sign off on the merger. If approved, come early 2025, Doylestown will be the seventh hospital in the Penn Medicine system.
At present, Doylestown Health is part of the Penn Cancer Network for more than 10 years.
“The integration of Doylestown Health into UPHS will enable us to expand access to care by providing leading-edge treatments and novel therapies – services that patients might have to travel far from home to receive - within their communities,” said University of Pennsylvania Health System President and CEO Kevin B. Mahoney in a statement. “Through this strategy, we join the best of Penn Medicine with the best of Doylestown Health to give patients as many convenient pathways as possible to outstanding care and support.”
“The joining of Doylestown Health into Penn Medicine will allow both organizations to provide the highest quality, cost-effective care, right where patients need it,” said Doylestown Health President and CEO Jim Brexler in a statement.
Other recent acquisitions by Penn Medicine, per the report, are Chester County Hospital, Lancaster General Hospital, and Princeton Health in New Jersey.
The recent acquisition comes at a time when many other health systems are merging to, well, keep themselves viable. Jefferson Health recently acquired Lehigh Valley Health Network earlier this month, for instance.
